You are currently viewing The Axxess Stent: from concept to long term clinical evidence

The Axxess Stent: from concept to long term clinical evidence

EBC - ON DEMAND

The Axxess Stent: from concept to long term clinical evidence

European Bifurcation Club 2012 – EBC 2012 – Castelldefels, Spain

BIOSENSORS

The Axxess Stent: from concept to long term clinical evidence

Author: Andrejs Erglis, MD Riga

 

CONCLUSION

  • The Axxess dedicated Biolimus A9 eluting bifurcation stent is easy to deploy once steps are understood
  • High procedural success rates with 99% delivery > 99 % angiographic success
  • Delivers over 1 wire, does not need to rotate or align with SB
  • SB protected
  • “Carina sparing”
  • The safety and efficacy of the Axxess Biolimus A9-eluting stent was confirmed up to 4 years
  • The DIVERGE study demonstrated excellent results:  all-cause cumulative MACE rate 18.5%
  • Ischemia-driven TLR rate 10.6%
  • very late definite stent thrombosis 1.0%

Download here

Leave a Reply